Yongzheng Zhang
Xinjiang Medical University(CN)Phio Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Peptides and Activities, Bacterial Genetics and Biotechnology, Antimicrobial Resistance in Staphylococcus
Most-Cited Works
- → Discovery of Brivanib Alaninate ((S)-((R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-yl)2-aminopropanoate), A Novel Prodrug of Dual Vascular Endothelial Growth Factor Receptor-2 and Fibroblast Growth Factor Receptor-1 Kinase Inhibitor (BMS-540215)(2008)141 cited
- → Pharmacokinetics and in vivo antistaphylococcal efficacy of TXY541, a 1-methylpiperidine-4-carboxamide prodrug of PC190723(2013)47 cited
- → Catalpol alleviates ovalbumin-induced asthma in mice: Reduced eosinophil infiltration in the lung(2016)40 cited
- → Inhibition of RND-type efflux pumps confers the FtsZ-directed prodrug TXY436 with activity against Gram-negative bacteria(2014)35 cited
- → Enterococcal and streptococcal resistance to PC190723 and related compounds: Molecular insights from a FtsZ mutational analysis(2013)26 cited
- → Evaluation of a Conformationally Constrained Indole Carboxamide as a Potential Efflux Pump Inhibitor in Pseudomonas aeruginosa(2022)20 cited
- → Combinatorial libraries based on a novel and readily accessible “centroid” scaffold(1998)19 cited
- → Evaluation of Heterocyclic Carboxamides as Potential Efflux Pump Inhibitors in Pseudomonas aeruginosa(2021)16 cited
- → Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis(2022)13 cited
- → Identification of macrophage driver genes in fibrosis caused by different heart diseases based on omics integration(2024)9 cited